Evidence map›Paper›PMID 39186757›Full record

ArticlePloS one2024

Situational assessment and epidemiology of HIV, HBV and HCV among people who use and inject drugs in Ghana.

Chris Guure, Samuel Dery, Carlota Baptista da Silva, Comfort Asamoah-Adu, Stephen Ayisi-Addo, Kofi Diaba, Maria-Goretti Loglo, Adamu Mohammed, Yaw Akrasi Sarpong, Samuel Hanu and 1 more

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Chris GuureDepartment of Biostatistics, School of Public Health, University of Ghana, Legon-Accra, Ghana.ORCID 0000-0001-6595-9587
Samuel DeryDepartment of Biostatistics, School of Public Health, University of Ghana, Legon-Accra, Ghana.
Carlota Baptista da SilvaInternational Consultant, Harm Reduction and Key population Expert, Lisbon, Portugal.
Comfort Asamoah-AduWest Africa Program to Combat AIDS, Accra, Ghana.
Stephen Ayisi-AddoNational AIDS/STI Control Programme, Ghana Health Service, Accra, Ghana.
Kofi DiabaWest Africa Program to Combat AIDS, Accra, Ghana.
Maria-Goretti LogloInternational Drug Policy Consortium, East Legon, Accra, Ghana.
Adamu MohammedWest Africa Behavioural Health Addictions and Recovery Management, Accra, Ghana.
Yaw Akrasi SarpongWest Africa Drug Policy Network (WADPN)-Ghana Chapter, Accra, Ghana.
Samuel HanuHarm Reduction Alliance Ghana, Accra, Ghana.
Kwasi TorpeyDepartment of Population Family and Reproductive Health, School of Public Health, University of Ghana, Legon-Accra, Ghana.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPeople who inject drugs (PWID) and people who use drugs (PWUD) are an important population group that remain under-served in Ghana. Though PWID and PWUD are among the key populations most-at-risk to acquire sexually transmitted or blood-borne diseases, they are among those with the least access to human immunodeficiency (HIV), hepatitis B (HBV) and hepatitis C (HCV) viruses' prevention, care and treatment services in Ghana due to lack of data on them. We provide a rapid assessment of the PWUD and PWID situation in Ghana.

methodsThis rapid cross-sectional design undertook consultative meetings between the study team and relevant stakeholders, including Civil Society Organizations (CSO) working with PWUD/PWID. The assessment considered a representative sample of PWID and PWUD. It was conducted in four (4) selected regions of Ghana (Greater Accra, Ashanti, Western, and Northern). Overall, 323 participants were interviewed using respondent-driven sampling (RDS) approach. Information obtained from participants were demographics, HIV risk behaviors, human immunodeficiency (HIV) and sexually transmitted infections (STI)-related knowledge HIV/HCV/HBV screening, attitude, and practices among others. Analyses were conducted using Stata version 17 and RDSAT version 7.1.46 software.

findingsDrug use was found to be more prevalent among the youth with a median age of 37 years. Majority of the respondents were males (86%). About 28% of the female respondents identified themselves as sex workers, while about 74% have been involved in transactional sex. The median age at which respondents started using and injecting drugs was 20 and 22 years respectively. Majority (68%) of the respondents consume drugs through smoking, with 20% through snorting, inhaling or swallowing and 12% through injection. The drug mostly used among the respondents was heroin (52%). The most commonly injected drug was cocaine (55%). About 64.7% of respondents reported mixing two or more drugs. HIV prevalence among respondents was 2.5%, 12.3% among women and 17.7% among women engaged in sex work, highlighting the overlap vulnerability. The prevalence of hepatitis C was 6.0%, and Hepatitis B was 4.5%. Access to care is limited, with 63% of the respondents never been tested for HIV.

conclusionThese rapid assessment findings reveal the challenging conditions for people who use and inject drugs coupled with a relatively high prevalence of HIV and Hepatitis C compared to the general population. However, it also reveals that Ghana has a window of opportunity to prevent an exponential spread of HIV and Hepatitis in this population. Therefore, there is the need to implement prevention and treatment programs for HIV and hepatitis among people who use and inject drugs including essential strategies for an enabling environment in Ghana.

Indexed as

Hepatitis BHepatitis CHIV InfectionsSubstance Abuse, IntravenousAdolescentAdultCross-Sectional StudiesDrug UsersFemaleGhanaHumansMaleMiddle AgedPrevalenceYoung Adult

Identifiers

PMID39186757
PMCPMC11346957

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.